China to study using CanSinoBIO Covid shots as a booster
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Sunday
January 29, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
SUNDAY, JANUARY 29, 2023
China to study using CanSinoBIO Covid shots as a booster

Coronavirus chronicle

Reuters
09 June, 2021, 04:40 pm
Last modified: 09 June, 2021, 04:43 pm

Related News

  • China central bank to roll over lending tools to spur growth
  • China approves two domestically developed Covid drugs
  • China's 2022 smartphone shipments the lowest in 10 years, research firm says
  • China aims to boost consumption and imports as global demand cools
  • H&M highlights fast-fashion gloom as luxury takes hit in China

China to study using CanSinoBIO Covid shots as a booster

China has not yet approved mixing doses of different vaccines using different technologies, but the director of the Chinese Center for Disease Control and Prevention said in April the country was considering it as a way of boosting vaccine efficacy

Reuters
09 June, 2021, 04:40 pm
Last modified: 09 June, 2021, 04:43 pm
Photo: Reuters
Photo: Reuters

Chinese researchers plan to study using a Covid-19 vaccine from CanSino Biologics as a booster shot for people who have already been inoculated with other vaccines, clinical trial registration data showed.

China has not yet approved mixing doses of different vaccines using different technologies, but the director of the Chinese Center for Disease Control and Prevention said in April the country was considering it as a way of boosting vaccine efficacy.

Five out of the seven vaccines used in China's inoculation campaign are inactivated, meaning they use a coronavirus that cannot replicate in human cells. These include the Sinovac shot and two vaccines from Sinopharm.

CanSinoBIO's shot uses a modified common cold virus known as adenovirus type-5 (Ad5) to carry genetic material from the coronavirus protein into the body.

A total of 300 healthy adults aged 18-59 years will be recruited for the trial.

Some participants who have received either one or two doses of inactivated vaccine will receive a booster shot from CanSinoBIO. The rest will be given the Sinovac vaccine as a booster for comparison.

The trial, which is currently recruiting participants, is sponsored by disease control authorities in the eastern province of Jiangsu, according to the clinical trial registration data on ClinicalTrials.gov, which is maintained by a department under the National Institute of Health of the United States.

The disease control authorities in Jiangsu are also running a trial that mixes doses produced by CanSinoBIO and a unit of Chongqing Zhifei Biological Products.

china / Chinese CanSino Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Getting gas to India will be even more costly than laying this pipe to China.Photographer: Andrey Rudakov/Bloomberg
    Russia can't replace the energy market Putin broke
  • Photo: UNB
    AL won't run away, rather will continue developing Bangladesh: PM in Rajshahi
  • Caretaker government most suitable system for credible polls: Fakhrul
    Caretaker government most suitable system for credible polls: Fakhrul

MOST VIEWED

  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs
  • Photo: Collected
    India launches world’s 1st intranasal Covid vaccine
  • A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  •  A medical worker checks the IV drip treatment of a patient lying on a bed in the emergency department of a hospital, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China, January 5, 2023. REUTERS/Staff
    China says Covid deaths down by nearly 80 percent
  • Sean Bagley, 14, receives the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    Updated Covid vaccines prevented illness from latest variants -CDC

Related News

  • China central bank to roll over lending tools to spur growth
  • China approves two domestically developed Covid drugs
  • China's 2022 smartphone shipments the lowest in 10 years, research firm says
  • China aims to boost consumption and imports as global demand cools
  • H&M highlights fast-fashion gloom as luxury takes hit in China

Features

Nandita Sharmin's journey to give organic skincare a new identity

Nandita Sharmin's journey to give organic skincare a new identity

6h | Mode
Illustration: TBS

'The silver lining is that the worst is sort of behind us': Hamid Rashid, UN economist

9h | Panorama
Photo: Bloomberg

BuzzFeed and AI are a match made in fad city

8h | Panorama
Snipe in flight. Photo: Enam Ul Haque

Baikka Beel: 'A world where snipe work late'

1d | Panorama

More Videos from TBS

Take your football game to the next level at Next Level academy

Take your football game to the next level at Next Level academy

51m | TBS SPORTS
“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

2h | TBS Round Table
What does Shahrukh has in his 770 million dollar property?

What does Shahrukh has in his 770 million dollar property?

22h | TBS Entertainment
15 Reasons Your Entrepreneurial Career Can Fail

15 Reasons Your Entrepreneurial Career Can Fail

21h | TBS Career

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

3
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

4
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

5
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]